Guest guest Posted May 2, 2011 Report Share Posted May 2, 2011 FDA Panel Unanimously Approves Experimental Hepatitis Drug From Vertex Pharma From the PharmaLive.com News Archive - Apr. 29, 2011 An FDA panel said an experimental hepatitis C drug from Vertex Pharmaceuticals is a significant step forward in treating the virus, despite a high rate of rashes among patients taking the tablet. The panel voted unanimously, 18-0, that the drug is a safe and effective treatment for hepatitis C. On Wednesday the same panel unanimously recommended approval for Merck's drug boceprevir. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.